Promising New Oral Antibiotic Effective Against Gonorrhoea in Trial

A global Phase III clinical trial has demonstrated high efficacy for zoliflodacin, a novel single-dose oral antibiotic. The drug achieved cure rates over 90% for uncomplicated urogenital gonorrhoea. These findings are significant as they offer a potential new treatment option to combat increasing drug-resistant strains of the infection.